Citius Oncology Names New Director as Insider Buying Surge Signals Exec Confidence in Growth Plan
New director Dr. Jonathan Peri joins Citius Oncology, boosting governance as insiders buy 4M+ shares, signaling confidence in LYMPHIR’s lymphoma potential.
2 minutes to read